Although our studies have demonstrated that FANCF silencing significantly increases MX sensitivity in vitro, it is critical to further define the role of FANCF in regulating MX sensitivity of breast cancer in vivo to evaluate the clinical significance of FANCF. The gene discussed is FANCF; the disease is breast carcinoma.